<?xml version="1.0" encoding="UTF-8"?>
<ref id="B108-pharmaceutics-13-00327">
 <label>108.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Craske</surname>
    <given-names>M.G.</given-names>
   </name>
   <name>
    <surname>Stein</surname>
    <given-names>M.B.</given-names>
   </name>
   <name>
    <surname>Eley</surname>
    <given-names>T.C.</given-names>
   </name>
   <name>
    <surname>Milad</surname>
    <given-names>M.R.</given-names>
   </name>
   <name>
    <surname>Holmes</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Rapee</surname>
    <given-names>R.M.</given-names>
   </name>
   <name>
    <surname>Wittchen</surname>
    <given-names>H.U.</given-names>
   </name>
  </person-group>
  <article-title>Anxiety disorders</article-title>
  <source>Nat. Rev. Dis. Primers</source>
  <year>2017</year>
  <volume>3</volume>
  <elocation-id>17024</elocation-id>
  <pub-id pub-id-type="doi">10.1038/nrdp.2017.24</pub-id>
  <?supplied-pmid 28470168?>
  <pub-id pub-id-type="pmid">28470168</pub-id>
 </element-citation>
</ref>
